Th. de Revel

Learn More
To assess the place of allogeneic hematopoietic stem cell transplantation (HSCT) in the advanced stage of acute myeloid leukemia (AML), we retrospectively analyzed 379 consecutive patients who(More)
The EMA86 study showed efficacy of intensive sequential chemotherapy with mitoxantrone, 12 mg/m2 day on days 1–3, etoposide, 200 mg/m2/day as a continuous infusion on days 8–10 and cytarabine (araC),(More)